122 related articles for article (PubMed ID: 14627984)
1. BH4-domain peptide from Bcl-xL exerts anti-apoptotic activity in vivo.
Sugioka R; Shimizu S; Funatsu T; Tamagawa H; Sawa Y; Kawakami T; Tsujimoto Y
Oncogene; 2003 Nov; 22(52):8432-40. PubMed ID: 14627984
[TBL] [Abstract][Full Text] [Related]
2. BH4 peptide derivative from Bcl-xL attenuates ischemia/reperfusion injury thorough anti-apoptotic mechanism in rat hearts.
Ono M; Sawa Y; Ryugo M; Alechine AN; Shimizu S; Sugioka R; Tsujimoto Y; Matsuda H
Eur J Cardiothorac Surg; 2005 Jan; 27(1):117-21. PubMed ID: 15621482
[TBL] [Abstract][Full Text] [Related]
3. Delivery of Bcl-XL or its BH4 domain by protein transduction inhibits apoptosis in human islets.
Klein D; Ribeiro MM; Mendoza V; Jayaraman S; Kenyon NS; Pileggi A; Molano RD; Inverardi L; Ricordi C; Pastori RL
Biochem Biophys Res Commun; 2004 Oct; 323(2):473-8. PubMed ID: 15369775
[TBL] [Abstract][Full Text] [Related]
4. Systemic delivery of BH4 anti-apoptotic peptide using CPPs prevents cardiac ischemia-reperfusion injuries in vivo.
Boisguerin P; Redt-Clouet C; Franck-Miclo A; Licheheb S; Nargeot J; Barrère-Lemaire S; Lebleu B
J Control Release; 2011 Dec; 156(2):146-53. PubMed ID: 21839124
[TBL] [Abstract][Full Text] [Related]
5. BH4 peptide derived from Bcl-xL and Bax-inhibitor peptide suppresses apoptotic mitochondrial changes in heat stressed bovine oocytes.
Soto P; Smith LC
Mol Reprod Dev; 2009 Jul; 76(7):637-46. PubMed ID: 19062170
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis-modulating interaction of the neuregulin/erbB pathway with anthracyclines in regulating Bcl-xS and Bcl-xL in cardiomyocytes.
Rohrbach S; Muller-Werdan U; Werdan K; Koch S; Gellerich NF; Holtz J
J Mol Cell Cardiol; 2005 Mar; 38(3):485-93. PubMed ID: 15733908
[TBL] [Abstract][Full Text] [Related]
7. Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress.
Cantara S; Donnini S; Giachetti A; Thorpe PE; Ziche M
J Vasc Res; 2004; 41(2):202-7. PubMed ID: 15031604
[TBL] [Abstract][Full Text] [Related]
8. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
Wu JS; Lin TN; Wu KK
J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
[TBL] [Abstract][Full Text] [Related]
10. Restriction of lipid motion in membranes triggered by beta-sheet aggregation of the anti-apoptotic BH4 domain.
Sani MA; Castano S; Dufourc EJ; Gröbner G
FEBS J; 2008 Feb; 275(3):561-72. PubMed ID: 18199286
[TBL] [Abstract][Full Text] [Related]
11. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death.
Shimizu S; Konishi A; Kodama T; Tsujimoto Y
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3100-5. PubMed ID: 10737788
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-induced renal epithelial cell death through caspase-dependent pathway: role of Bcl-2, Bcl-xL and Bax in tubular injury.
Yamamoto K; Tomita N; Yoshimura S; Nakagami H; Taniyama Y; Yamasaki K; Ogihara T; Morishita R
Int J Mol Med; 2004 Oct; 14(4):633-40. PubMed ID: 15375594
[TBL] [Abstract][Full Text] [Related]
13. Bcl-xES, a BH4- and BH2-containing antiapoptotic protein, delays Bax oligomer formation and binds Apaf-1, blocking procaspase-9 activation.
Schmitt E; Paquet C; Beauchemin M; Bertrand R
Oncogene; 2004 May; 23(22):3915-31. PubMed ID: 15048082
[TBL] [Abstract][Full Text] [Related]
14. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
[TBL] [Abstract][Full Text] [Related]
15. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis.
Chipuk JE; Kuwana T; Bouchier-Hayes L; Droin NM; Newmeyer DD; Schuler M; Green DR
Science; 2004 Feb; 303(5660):1010-4. PubMed ID: 14963330
[TBL] [Abstract][Full Text] [Related]
16. Ischemic but not mechanical preconditioning attenuates ischemia/reperfusion induced myocardial apoptosis in anaesthetized rabbits: the role of Bcl-2 family proteins and ERK1/2.
Lazou A; Iliodromitis EK; Cieslak D; Voskarides K; Mousikos S; Bofilis E; Kremastinos DT
Apoptosis; 2006 Dec; 11(12):2195-204. PubMed ID: 17051325
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin inhibits cell growth by induction of apoptosis on hepatocellular carcinoma cells in vitro.
Zhang JF; Liu JJ; Lu MQ; Cai CJ; Yang Y; Li H; Xu C; Chen GH
Transpl Immunol; 2007 Apr; 17(3):162-8. PubMed ID: 17331842
[TBL] [Abstract][Full Text] [Related]
18. Glucosamine sulfate-induced apoptosis in chronic myelogenous leukemia K562 cells is associated with translocation of cathepsin D and downregulation of Bcl-xL.
Wang Z; Liang R; Huang GS; Piao Y; Zhang YQ; Wang AQ; Dong BX; Feng JL; Yang GR; Guo Y
Apoptosis; 2006 Oct; 11(10):1851-60. PubMed ID: 16850161
[TBL] [Abstract][Full Text] [Related]
19. Limited protection of TAT-Bcl-X(L) against pneumolysin-induced neuronal cell death.
Ebert S; Dietz GP; Mitchell TJ; Michel U; Bähr M; Nau R
Neurosci Lett; 2005 Aug; 384(3):349-53. PubMed ID: 15961228
[TBL] [Abstract][Full Text] [Related]
20. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway.
Maddika S; Booy EP; Johar D; Gibson SB; Ghavami S; Los M
J Cell Sci; 2005 Oct; 118(Pt 19):4485-93. PubMed ID: 16179607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
